On the other hand, when JMJD2A was overexpressed, the average xenograft tumor appearance time was decreased compared to the corresponding control group (5.54286 ± 0.75687 days versus 9.15857 ± 2.36918 days, P = 0.0031 < 0.01). The gene discussed is KDM4A; the disease is neoplasm.